Thymosins in multiple sclerosis and its experimental models: moving from basic to clinical application

Background: Multiple sclerosis (MS) afflicts more than 2.5 million individuals worldwide and this number is increasing over time. Within the past years, a great number of disease-modifying treatments have emerged; however, efficacious treatments and a cure for MS await discovery. Thymosins, soluble...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Mult Scler Relat Disord
Auteurs principaux: Severa, Martina, Zhang, Jing, Giacomini, Elena, Rizzo, Fabiana, Etna, Marilena Paola, Cruciani, Melania, Garaci, Enrico, Chopp, Michael, Coccia, Eliana Marina
Format: Artigo
Langue:Inglês
Publié: Elsevier B.V. 2019
Sujets:
Review article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7104151/
https://ncbi.nlm.nih.gov/pubmed/30317071
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.msard.2018.09.035
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires